New Paper Shows Follow On Patents Are Common, and Commonly Extend the Patent Life of Pharmaceuticals
[by Amy Kapczynski] Chan Park, Bhaven Sampat and I recently published in PLoS, perhaps of interest to folks here. We provide data about the ubiquity and significance of so-called “secondary” patents in pharma (e.g. salt patents, polymorph patents, dosage and…